Scandinavian Medical Solutions A/S
SMSMED.CO · CPH
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | DKK 245 | DKK 227 | DKK 191 | DKK 111 |
| % Growth | 8.3% | 18.6% | 73% | – |
| Cost of Goods Sold | DKK 211 | DKK 187 | DKK 156 | DKK 88 |
| Gross Profit | DKK 34 | DKK 40 | DKK 35 | DKK 23 |
| % Margin | 14% | 17.7% | 18.2% | 20.5% |
| R&D Expenses | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| G&A Expenses | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| SG&A Expenses | DKK 0 | DKK 19 | DKK 0 | DKK 7 |
| Sales & Mktg Exp. | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Other Operating Expenses | DKK 32 | DKK 7 | DKK 18 | DKK 0 |
| Operating Expenses | DKK 32 | DKK 26 | DKK 18 | DKK 8 |
| Operating Income | DKK 2 | DKK 14 | DKK 17 | DKK 15 |
| % Margin | 0.7% | 6.1% | 8.7% | 13.3% |
| Other Income/Exp. Net | -DKK 2 | -DKK 4 | -DKK 1 | -DKK 0 |
| Pre-Tax Income | DKK 0 | DKK 10 | DKK 16 | DKK 15 |
| Tax Expense | DKK 0 | DKK 2 | DKK 4 | DKK 3 |
| Net Income | DKK 0 | DKK 8 | DKK 12 | DKK 11 |
| % Margin | 0% | 3.4% | 6.4% | 10.3% |
| EPS | 0.001 | 0.28 | 0.45 | 0.43 |
| % Growth | -99.7% | -37.8% | 4.7% | – |
| EPS Diluted | 0.001 | 0.28 | 0.45 | 0.43 |
| Weighted Avg Shares Out | 28 | 27 | 27 | 27 |
| Weighted Avg Shares Out Dil | 28 | 27 | 27 | 27 |
| Supplemental Information | – | – | – | – |
| Interest Income | DKK 1 | DKK 2 | DKK 0 | DKK 0 |
| Interest Expense | DKK 2 | DKK 5 | DKK 1 | DKK 0 |
| Depreciation & Amortization | DKK 9 | DKK 7 | DKK 4 | DKK 1 |
| EBITDA | DKK 11 | DKK 21 | DKK 21 | DKK 16 |
| % Margin | 4.5% | 9.3% | 11.1% | 14.1% |